{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:36:48Z","timestamp":1794587808447,"version":"4.9.1"},"reference-count":64,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CG"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Rare genetic disorders collectively affect millions of individuals worldwide, presenting a\nsignificant clinical and research challenge due to the diversity and complexity of the underlying\nmutations. Current treatment options are often limited, focusing on symptom management rather\nthan addressing the root genetic causes. This review article aims to provide a perspective on the\nevolving field of gene therapy for rare genetic disorders, emphasizing recent advancements, current\nchallenges, and future directions. A comprehensive review of recent advancements in gene therapy\nfor rare genetic disorders was conducted, focusing on therapeutic strategies, delivery systems, and\nclinical outcomes. Key examples, such as the use of viral vectors and gene-editing technologies\n(e.g., CRISPR), were highlighted. The challenges, including immune responses and ethical concerns,\nwere also examined. Gene therapy has achieved significant milestones, with the successful\ndevelopment of therapies like &lt;i&gt;Zolgensma&lt;\/i&gt; for spinal muscular atrophy and Luxturna for retinal dystrophy.\nHowever, several hurdles, including efficient gene delivery, immune reactions, and longterm\nsafety, remain unresolved. Gene therapy holds transformative potential for the treatment of rare\ngenetic disorders. While recent successes mark a new era in genetic medicine, ongoing research\nis required to refine delivery mechanisms, overcome immune-related barriers, and ensure ethical\nand safe therapeutic interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892029361490250310041259","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T23:20:52Z","timestamp":1742167252000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gene Therapy in Rare Genetic Disorders: Current Progress and Future Perspectives"],"prefix":"10.2174","volume":"26","author":[{"given":"Sundus","family":"Khawaja","sequence":"first","affiliation":[{"name":"Department of Biotechnology, University of Azad Jammu and Kashmir, Muzaffarabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Hussain","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Boston Children's Hospital, Harvard Medical School, Teaching Hospital, Boston, Massachusetts,USA"},{"name":"Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC),King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGH), Riyadh,Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishtiaq","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Biotechnology, Pir Mehr Ali Shah Arid Agriculture University Rawalpindi46000, Pakistan"},{"name":"Metropole Laboratories (Private) Limited, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6729-9746","authenticated-orcid":true,"given":"Muhammad","family":"Umair","sequence":"additional","affiliation":[{"name":"Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC),King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGH), Riyadh,Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"Nguengang Wakap S.","year":"2020","unstructured":"Nguengang Wakap S.; Lambert D.M.; Olry A.; Rodwell C.; Gueydan C.; Lanneau V.; Murphy D.; Le Cam Y.; Rath A.; Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur J Hum Genet  2020,28(2),165-173","journal-title":"Eur J Hum Genet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ajmg.a.61124","volume":"179","author":"Ferreira C.R.","year":"2019","unstructured":"Ferreira C.R.; The burden of rare diseases. Am J Med Genet A  2019,179(6),885-892","journal-title":"Am J Med Genet A"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","volume":"57","author":"Brady R.O.","year":"2006","unstructured":"Brady R.O.; Enzyme replacement for lysosomal diseases. Annu Rev Med  2006,57(1),283-296","journal-title":"Annu Rev Med"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3503","volume":"25","author":"Umair M.","year":"2023","unstructured":"Umair M.; Rare genetic disorders: Beyond whole\u2010exome sequencing. J Gene Med  2023,25(10)","journal-title":"J Gene Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10928-023-09859-7","volume":"50","author":"Barrett J.S.","year":"2023","unstructured":"Barrett J.S.; Betourne A.; Walls R.L.; Lasater K.; Russell S.; Borens A.; Rohatagi S.; Roddy W.; The future of rare disease drug development: The rare disease cures accelerator data analytics platform (RDCA-DAP). J Pharmacokinet Pharmacodyn  2023,50(6),507-519","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/s1679-45082017rb4024","volume":"15","author":"Gon\u00e7alves G.A.R.","year":"2017","unstructured":"Gon\u00e7alves G.A.R.; Paiva R.M.A.; Gene therapy: Advances, challenges and perspectives. Einstein (Sao Paulo)  2017,15(3),369-375","journal-title":"Einstein (Sao Paulo)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ajps.2021.05.003","volume":"16","author":"Pan X.","year":"2021","unstructured":"Pan X.; Veroniaina H.; Su N.; Sha K.; Jiang F.; Wu Z.; Qi X.; Applications and developments of gene therapy drug delivery systems for genetic diseases. Asian J Pharm Sci  2021,16(6),687-703","journal-title":"Asian J Pharm Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0022034509337480","volume":"88","author":"Scheller E.L.","year":"2009","unstructured":"Scheller E.L.; Krebsbach P.H.; Gene therapy: Design and prospects for craniofacial regeneration. J Dent Res  2009,88(7),585-596","journal-title":"J Dent Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fonc.2020.01387","volume":"10","author":"Uddin F.","year":"2020","unstructured":"Uddin F.; Rudin C.M.; Sen T.; CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. Front Oncol  2020,10,1387","journal-title":"Front Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"Raguram A.","year":"2022","unstructured":"Raguram A.; Banskota S.; Liu D.R.; Therapeutic in vivo delivery of gene editing agents. Cell  2022,185(15),2806-2827","journal-title":"Cell"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"Mendell J.R.","year":"2017","unstructured":"Mendell J.R.; Al-Zaidy S.; Shell R.; Arnold W.D.; Rodino-Klapac L.R.; Prior T.W.; Lowes L.; Alfano L.; Berry K.; Church K.; Kissel J.T.; Nagendran S.; L\u2019Italien J.; Sproule D.M.; Wells C.; Cardenas J.A.; Heitzer M.D.; Kaspar A.; Corcoran S.; Braun L.; Likhite S.; Miranda C.; Meyer K.; Foust K.D.; Burghes A.H.M.; Kaspar B.K.; Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med  2017,377(18),1713-1722","journal-title":"N Engl J Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2988","volume":"12","author":"Mingozzi F.","year":"2011","unstructured":"Mingozzi F.; High K.A.; Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat Rev Genet  2011,12(5),341-355","journal-title":"Nat Rev Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/aps.2017.2","volume":"38","author":"Shim G.","year":"2017","unstructured":"Shim G.; Kim D.; Park G.T.; Jin H.; Suh S.K.; Oh Y.K.; Therapeutic gene editing: Delivery and regulatory perspectives. Acta Pharmacol Sin  2017,38(6),738-753","journal-title":"Acta Pharmacol Sin"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.yapd.2019.04.001","volume":"66","author":"Steffin D.H.M.","year":"2019","unstructured":"Steffin D.H.M.; Hsieh E.M.; Rouce R.H.; Gene therapy. Adv Pediatr  2019,66,37-54","journal-title":"Adv Pediatr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"Hsu P.D.","year":"2014","unstructured":"Hsu P.D.; Lander E.S.; Zhang F.; Development and applications of CRISPR-Cas9 for genome engineering. Cell  2014,157(6),1262-1278","journal-title":"Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.gendis.2023.02.027","volume":"11","author":"Khoshandam M.","year":"2024","unstructured":"Khoshandam M.; Soltaninejad H.; Mousazadeh M.; Hamidieh A.A.; Hosseinkhani S.; Clinical applications of the CRISPR\/Cas9 genome-editing system: Delivery options and challenges in precision medicine. Genes Dis  2024,11(1),268-282","journal-title":"Genes Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1007\/s11033-022-07880-6","volume":"49","author":"Javaid D.","year":"2022","unstructured":"Javaid D.; Ganie S.Y.; Hajam Y.A.; Reshi M.S.; CRISPR\/Cas9 system: A reliable and facile genome editing tool in modern biology. Mol Biol Rep  2022,49(12),12133-12150","journal-title":"Mol Biol Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1172\/JCI72992","volume":"124","author":"Gupta R.M.","year":"2014","unstructured":"Gupta R.M.; Musunuru K.; Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J Clin Invest  2014,124(10),4154-4161","journal-title":"J Clin Invest"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5528\/wjtm.v5.i1.1","volume":"5","author":"Raikwar S.P.","year":"2016","unstructured":"Raikwar S.P.; Raikwar A.S.; Chaurasia S.S.; Mohan R.R.; Gene editing for corneal disease management. World J Transl Med  2016,5(1),1-13","journal-title":"World J Transl Med"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049874","volume":"16","author":"Richardson C.","year":"2023","unstructured":"Richardson C.; Kelsh R.N.; J Richardson; R. New advances in CRISPR\/Cas-mediated precise gene-editing techniques. Dis Model Mech  2023,16(2)","journal-title":"Dis Model Mech"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"Rees H.A.","year":"2018","unstructured":"Rees H.A.; Liu D.R.; Base editing: Precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet  2018,19(12),770-788","journal-title":"Nat Rev Genet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/21645515.2020.1757989","volume":"17","author":"De Haan P.","year":"2021","unstructured":"De Haan P.; Van Diemen F.R.; Toscano M.G.; Viral gene delivery vectors: The next generation medicines for immune-related diseases. Hum Vaccin Immunother  2021,17(1),14-21","journal-title":"Hum Vaccin Immunother"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1172\/JCI32949","volume":"117","author":"Bushman F.D.","year":"2007","unstructured":"Bushman F.D.; Retroviral integration and human gene therapy. J Clin Invest  2007,117(8),2083-2086","journal-title":"J Clin Invest"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","volume":"7","author":"Travieso T.","year":"2022","unstructured":"Travieso T.; Li J.; Mahesh S.; Mello J.D.F.R.E.; Blasi M.; The use of viral vectors in vaccine development. NPJ Vaccines  2022,7(1),75","journal-title":"NPJ Vaccines"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/B978-012253840-7\/50006-7","volume":"2","author":"Von Seggern D.J.","year":"2007","unstructured":"Von Seggern D.J.; Nemerow G.R.; Adenoviral vectors for protein expression. Gene. Express. Syst  2007,2,111-156","journal-title":"Syst"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"Wang D.","year":"2019","unstructured":"Wang D.; Tai P.W.L.; Gao G.; Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov  2019,18(5),358-378","journal-title":"Nat Rev Drug Discov"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/genes13081370","volume":"13","author":"Butt M.","year":"2022","unstructured":"Butt M.; Zaman M.; Ahmad A.; Khan R.; Mallhi T.; Hasan M.; Khan Y.; Hafeez S.; Massoud E.; Rahman M.; Cavalu S.; Appraisal for the potential of viral and nonviral vectors in gene therapy: A review. Genes (Basel)  2022,13(8),1370","journal-title":"Genes (Basel)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature08956","volume":"464","author":"Davis M.E.","year":"2010","unstructured":"Davis M.E.; Zuckerman J.E.; Choi C.H.J.; Seligson D.; Tolcher A.; Alabi C.A.; Yen Y.; Heidel J.D.; Ribas A.; Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature  2010,464(7291),1067-1070","journal-title":"Nature"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.06.051","volume":"347","author":"Bilensoy E.","year":"2008","unstructured":"Bilensoy E.; G\u00fcrkaynak O.; Do\u011fan A.L.; H\u0131ncal A.A.; Safety and efficacy of amphiphilic \u00df-cyclodextrin nanoparticles for paclitaxel delivery. Int J Pharm  2008,347(1-2),163-170","journal-title":"Int J Pharm"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1021\/mp3003946","volume":"10","author":"Godinho B.M.D.C.","year":"2013","unstructured":"Godinho B.M.D.C.; Ogier J.R.; Darcy R.; O\u2019Driscoll C.M.; Cryan J.F.; Self-assembling modified \u03b2-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: Focus on Huntington\u2019s disease. Mol Pharm  2013,10(2),640-649","journal-title":"Mol Pharm"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4155\/tde-2022-0036","volume":"13","author":"Quintas P.C.","year":"2022","unstructured":"Quintas P.C.; Al-Salami H.; Pfaff A.; Li D.; Koks S.; \u03b2-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome. Ther Deliv  2022,13(9),449-462","journal-title":"Ther Deliv"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biom13091346","volume":"13","author":"K\u00f5ks S.","year":"2023","unstructured":"K\u00f5ks S.; Genomics of wolfram syndrome 1 (WFS1). Biomolecules  2023,13(9),1346","journal-title":"Biomolecules"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.addr.2011.08.002","volume":"63","author":"Plank C.","year":"2011","unstructured":"Plank C.; Zelphati O.; Mykhaylyk O.; Magnetically enhanced nucleic acid delivery. ten years of magnetofection\u2014progress and prospects. Adv Drug Deliv Rev  2011,63(14-15),1300-1331","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2021.107871","author":"Batista Napotnik T.","year":"2021","unstructured":"Batista Napotnik T.; Polaj\u017eer T.; Miklav\u010di\u010d D.; Cell death due to electroporation \u2013 A review. Bioelectrochemistry  2021","journal-title":"Bioelectrochemistry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nprot.2006.145","volume":"1","author":"O\u2019Brien J.A.","year":"2006","unstructured":"O\u2019Brien J.A.; Lummis S.C.R.; Biolistic transfection of neuronal cultures using a hand-held gene gun. Nat Protoc  2006,1(2),977-981","journal-title":"Nat Protoc"},{"key":"ref=36","first-page":"195","volume":"1","author":"Adams J.","year":"2008","unstructured":"Adams J.; Transcriptome: Connecting the genome to gene function. Nat Educator  2008,1(1),195","journal-title":"Nat Educator"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1535370220954788","volume":"246","author":"Koks G.","year":"2021","unstructured":"Koks G.; Pfaff A.L.; Bubb V.J.; Quinn J.P.; Koks S.; At the dawn of the transcriptomic medicine. Exp Biol Med (Maywood)  2021,246(3),286-292","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702636","author":"Bode D.","year":"2021","unstructured":"Bode D.; Cull A.H.; Rubio-Lara J.A.; Kent D.G.; Exploiting single-cell tools in gene and cell therapy. Front Immunol  2021","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/mus.27363","volume":"64","author":"Kichula E.A.","year":"2021","unstructured":"Kichula E.A.; Proud C.M.; Farrar M.A.; Kwon J.M.; Saito K.; Desguerre I.; McMillan H.J.; Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy. Muscle Nerve  2021,64(4),413-427","journal-title":"Muscle Nerve"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.3390\/ijms241813743","volume":"24","author":"Ponomarev A.S.","year":"2023","unstructured":"Ponomarev A.S.; Chulpanova D.S.; Yanygina L.M.; Solovyeva V.V.; Rizvanov A.A.; Emerging gene therapy approaches in the management of spinal muscular atrophy (SMA): An overview of clinical trials and patent landscape. Int J Mol Sci  2023,24(18),13743","journal-title":"Int J Mol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.3390\/ijms22094534","volume":"22","author":"Chiu W.","year":"2021","unstructured":"Chiu W.; Lin T.Y.; Chang Y.C.; Lai I.A.M.H.; Lin S.C.; Ma C.; Yarmishyn A.A.; Lin S.C.; Chang K.J.; Chou Y.B.; Hsu C.C.; Lin T.C.; Chen S.J.; Chien Y.; Yang Y.P.; Hwang D.K.; An update on gene therapy for inherited retinal dystrophy: Experience in Leber congenital amaurosis clinical trials. Int J Mol Sci  2021,22(9),4534","journal-title":"Int J Mol Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"13756","DOI":"10.3390\/ijms241813756","volume":"24","author":"Malvasi M.","year":"2023","unstructured":"Malvasi M.; Casillo L.; Avogaro F.; Abbouda A.; Vingolo E.M.; Gene therapy in hereditary retinal dystrophies: The usefulness of diagnostic tools in candidate patient selections. Int J Mol Sci  2023,24(18),13756","journal-title":"Int J Mol Sci"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1015926","author":"Sui H.","year":"2022","unstructured":"Sui H.; Xu X.; Su Y.; Gong Z.; Yao M.; Liu X.; Zhang T.; Jiang Z.; Bai T.; Wang J.; Zhang J.; Xu C.; Luo M.; Gene therapy for cystic fibrosis: Challenges and prospects. Front Pharmacol  2022","journal-title":"Front Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.814174","author":"Manini A.","year":"2022","unstructured":"Manini A.; Abati E.; Nuredini A.; Corti S.; Comi G.P.; Adeno-associated virus (AAV)-mediated gene therapy for Duchenne muscular dystrophy: The issue of transgene persistence. Front Neurol  2022","journal-title":"Front Neurol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/hematology.2022000388","volume":"2022","author":"Nathwani A.C.","year":"2022","unstructured":"Nathwani A.C.; Gene therapy for hemophilia. Hematology (Am Soc Hematol Educ Program)  2022,2022(1),569-578","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/biom14070854","volume":"14","author":"Chernyi N.","year":"2024","unstructured":"Chernyi N.; Gavrilova D.; Saruhanyan M.; Oloruntimehin E.S.; Karabelsky A.; Bezsonov E.; Malogolovkin A.; Recent advances in gene therapy for hemophilia: Projecting the perspectives. Biomolecules  2024,14(7),854","journal-title":"Biomolecules"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"16034","DOI":"10.1038\/mtm.2016.34","volume":"3","author":"Kumar S.R.P.","year":"2016","unstructured":"Kumar S.R.P.; Markusic D.M.; Biswas M.; High K.A.; Herzog R.W.; Clinical development of gene therapy: Results and lessons from recent successes. Mol Ther Methods Clin Dev  2016,3,16034","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"Deverman B.E.","year":"2018","unstructured":"Deverman B.E.; Ravina B.M.; Bankiewicz K.S.; Paul S.M.; Sah D.W.Y.; Gene therapy for neurological disorders: Progress and prospects. Nat Rev Drug Discov  2018,17(9),641-659","journal-title":"Nat Rev Drug Discov"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"Cox D.B.T.","year":"2015","unstructured":"Cox D.B.T.; Platt R.J.; Zhang F.; Therapeutic genome editing: Prospects and challenges. Nat Med  2015,21(2),121-131","journal-title":"Nat Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"Shirley J.L.","year":"2020","unstructured":"Shirley J.L.; de Jong Y.P.; Terhorst C.; Herzog R.W.; Immune responses to viral gene therapy vectors. Mol Ther  2020,28(3),709-722","journal-title":"Mol Ther"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675897","author":"Hamilton B.A.","year":"2021","unstructured":"Hamilton B.A.; Wright J.F.; Challenges posed by immune responses to AAV vectors: Addressing root causes. Front Immunol  2021","journal-title":"Front Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/ijms21113903","volume":"21","author":"Maule G.","year":"2020","unstructured":"Maule G.; Arosio D.; Cereseto A.; Gene therapy for cystic fibrosis: Progress and challenges of genome editing. Int J Mol Sci  2020,21(11),3903","journal-title":"Int J Mol Sci"},{"key":"ref=53","first-page":"67","volume":"18","author":"Wang D.","year":"2014","unstructured":"Wang D.; Gao G.; State-of-the-art human gene therapy: Part I. Gene delivery technologies. Discov Med  2014,18(97),67-77","journal-title":"Discov Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","volume":"142","author":"Hunt J.M.T.","year":"2023","unstructured":"Hunt J.M.T.; Samson C.A.; Rand A.; Sheppard H.M.; Unintended CRISPR-Cas9 editing outcomes: A review of the detection and prevalence of structural variants generated by gene-editing in human cells. Hum Genet  2023,142(6),705-720","journal-title":"Hum Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/crispr.2024.0021","volume":"7","author":"Waltz M.","year":"2024","unstructured":"Waltz M.; Walker R.L.; Flatt M.A.; MacKay D.; Conley J.M.; Juengst E.T.; Cadigan R.J.; Challenging the boundaries between treatment, prevention, and enhancement in human genome editing. CRISPR J  2024,7(4),180-187","journal-title":"CRISPR J"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41587-021-00993-6","volume":"39","author":"Fang L.T.","year":"2021","unstructured":"Fang L.T.; Zhu B.; Zhao Y.; Chen W.; Yang Z.; Kerrigan L.; Langenbach K.; de Mars M.; Lu C.; Idler K.; Jacob H.; Zheng Y.; Ren L.; Yu Y.; Jaeger E.; Schroth G.P.; Abaan O.D.; Talsania K.; Lack J.; Shen T.W.; Chen Z.; Stanbouly S.; Tran B.; Shetty J.; Kriga Y.; Meerzaman D.; Nguyen C.; Petitjean V.; Sultan M.; Cam M.; Mehta M.; Hung T.; Peters E.; Kalamegham R.; Sahraeian S.M.E.; Mohiyuddin M.; Guo Y.; Yao L.; Song L.; Lam H.Y.K.; Drabek J.; Vojta P.; Maestro R.; Gasparotto D.; K\u00f5ks S.; Reimann E.; Scherer A.; Nordlund J.; Liljedahl U.; Jensen R.V.; Pirooznia M.; Li Z.; Xiao C.; Sherry S.T.; Kusko R.; Moos M.; Donaldson E.; Tezak Z.; Ning B.; Tong W.; Li J.; Duerken-Hughes P.; Catalanotti C.; Maheshwari S.; Shuga J.; Liang W.S.; Keats J.; Adkins J.; Tassone E.; Zismann V.; McDaniel T.; Trent J.; Foox J.; Butler D.; Mason C.E.; Hong H.; Shi L.; Wang C.; Xiao W.; Abaan O.D.; Ashby M.; Aygun O.; Bian X.; Blomquist T.M.; Bushel P.; Cam M.; Campagne F.; Chen Q.; Chen T.; Chen X.; Chen Y-C.; Chuang H-Y.; de Mars M.; Deng Y.; Donaldson E.; Drabek J.; Ernest B.; Foox J.; Freed D.; Giresi P.; Gong P.; Granat A.; Guan M.; Guo Y.; Hatzis C.; Hester S.; Hipp J.A.; Hong H.; Hung T.; Idler K.; Jacob H.; Jaeger E.; Jailwala P.; Jensen R.V.; Jones W.; Kalamegham R.; Kanakamedala B.; Keats J.; Kerrigan L.; K\u00f5ks S.; Kriga Y.; Kusko R.; Lababidi S.; Langenbach K.; Lee E.; Li J-L.; Li Y.; Li Z.; Liang S.; Liu X.; Lu C.; Maestro R.; Mason C.E.; McDaniel T.; Mercer T.; Meerzaman D.; Mehra U.; Miles C.; Miller C.; Moos M.; Moshrefi A.; Natarajan A.; Ning B.; Nordlund J.; Nguyen C.; Pandey J.; Papas B.N.; Pathak A.; Peters E.; Petitjean V.; Pirooznia M.; Polano M.; Raziuddin A.; Resch W.; Ren L.; Scherer A.; Schroth G.P.; Seifuddin F.; Sherry S.T.; Shetty J.; Shi L.; Shi T.; Staudt L.M.; Sultan M.; Tezak Z.; Tong W.; Tran B.; Trent J.; Truong T.; Vojta P.; Vera C.J.; Walton A.; Wang C.; Wang J.; Wang J.; Wang M.; Willey J.C.; Wu L.; Xiao C.; Xiao W.; Xu X.; Yan C.; Yavas G.; Yu Y.; Zhang C.; Zheng Y.; Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat Biotechnol  2021,39(9),1151-1160","journal-title":"Nat Biotechnol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"Kim J.J.","year":"2024","unstructured":"Kim J.J.; Vitale D.; Otani D.V.; Lian M.M.; Heilbron K.; Aslibekyan S.; Auton A.; Babalola E.; Bell R.K.; Bielenberg J.; Bryc K.; Bullis E.; Cannon P.; Coker D.; Partida G.C.; Dhamija D.; Das S.; Elson S.L.; Eriksson N.; Filshtein T.; Fitch A.; Fletez-Brant K.; Fontanillas P.; Freyman W.; Granka J.M.; Hernandez A.; Hicks B.; Hinds D.A.; Jewett E.M.; Jiang Y.; Kukar K.; Kwong A.; Lin K-H.; Llamas B.A.; Lowe M.; McCreight J.C.; McIntyre M.H.; Micheletti S.J.; Moreno M.E.; Nandakumar P.; Nguyen D.T.; Noblin E.S.; O\u2019Connell J.; Petrakovitz A.A.; Poznik G.D.; Reynoso A.; Schloetter M.; Schumacher M.; Shastri A.J.; Shelton J.F.; Shi J.; Shringarpure S.; Su Q.J.; Tat S.A.; Tchakout\u00e9 C.T.; Tran V.; Tung J.Y.; Wang X.; Wang W.; Weldon C.H.; Wilton P.; Wong C.D.; Iwaki H.; Lake J.; Solsberg C.W.; Leonard H.; Makarious M.B.; Tan E-K.; Singleton A.B.; Bandres-Ciga S.; Noyce A.J.; Gatto E.M.; Kauffman M.; Khachatryan S.; Tavadyan Z.; Shepherd C.E.; Hunter J.; Kumar K.; Ellis M.; Renter\u00eda M.E.; Koks S.; Zimprich A.; Schumacher-Schuh A.F.; Rieder C.; Awad P.S.; Tumas V.; Camargos S.; Fon E.A.; Monchi O.; Fon T.; Galleguillos B.P.; Miranda M.; Bustamante M.L.; Olguin P.; Chana P.; Tang B.; Shang H.; Guo J.; Chan P.; Luo W.; Arboleda G.; Orozc J.; del Rio M.J.; Hernandez A.; Salama M.; Kamel W.A.; Zewde Y.Z.; Brice A.; Corvol J-C.; Westenberger A.; Illarionova A.; Mollenhauer B.; Klein C.; Vollstedt E-J.; Hopfner F.; H\u00f6glinger G.; Madoev H.; Trinh J.; Junker J.; Lohmann K.; Lange L.M.; Sharma M.; Groppa S.; Gasser T.; Fang Z-H.; Akpalu A.; Xiromerisiou G.; Hadjigorgiou G.; Dagklis I.; Tarnanas I.; Stefanis L.; Stamelou M.; Dadiotis E.; Medina A.; Chan G.H-F.; Ip N.; Cheung N.Y-F.; Chan P.; Zhou X.; Kishore A.; Divya K.P.; Pal P.; Kukkle P.L.; Rajan R.; Borgohain R.; Salari M.; Quattrone A.; Valente E.M.; Parnetti L.; Avenali M.; Schirinzi T.; Funayama M.; Hattori N.; Shiraishi T.; Karimova A.; Kaishibayeva G.; Shambetova C.; Kr\u00fcger R.; Tan A.H.; Ahmad-Annuar A.; Norlinah M.I.; Murad N.A.A.; Azmin S.; Lim S-Y.; Mohamed W.; Tay Y.W.; Martinez-Ramirez D.; Rodriguez-Violante M.; Reyes-P\u00e9rez P.; Tserensodnom B.; Ojha R.; Anderson T.J.; Pitcher T.L.; Sanyaolu A.; Okubadejo N.; Ojo O.; Aasly J.O.; Pihlstr\u00f8m L.; Tan M.; Ur-Rehman S.; Veliz-Otani D.; Cornejo-Olivas M.; Doquenia M.L.; Rosales R.; Vinuela A.; Iakovenko E.; Mubarak B.A.; Umair M.; Amod F.; Carr J.; Bardien S.; Jeon B.; Kim Y.J.; Cubo E.; Alvarez I.; Hoenicka J.; Beyer K.; Peri\u00f1an M.T.; Pastor P.; El-Sadig S.; Brolin K.; Zweier C.; Tinkhauser G.; Krack P.; Lin C-H.; Wu H-C.; Kung P-J.; Wu R-M.; Wu Y.; Amouri R.; Sassi S.B.; Ba\u015fak A.N.; Genc G.; \u00c7akmak \u00d6.\u00d6.; Ertan S.; Mart\u00ednez-Carrasco A.; Schrag A.; Schapira A.; Carroll C.; Bale C.; Grosset D.; Stafford E.J.; Houlden H.; Morris H.R.; Hardy J.; Mok K.Y.; Rizig M.; Wood N.; Williams N.; Okunoye O.; Lewis P.A.; Kaiyrzhanov R.; Weil R.; Love S.; Stott S.; Jasaityte S.; Dey S.; Obese V.; Espay A.; O\u2019Grady A.; Sobering A.K.; Siddiqi B.; Casey B.; Fiske B.; Jonas C.; Cruchaga C.; Pantazis C.B.; Comart C.; Wegel C.; Hall D.; Hernandez D.; Shiamim E.; Riley E.; Faghri F.; Serrano G.E.; Chen H.; Mata I.F.; Sarmiento I.J.K.; Williamson J.; Jankovic J.; Shulman J.; Solle J.C.; Murphy K.; Nuytemans K.; Kieburtz K.; Markopoulou K.; Marek K.; Levine K.S.; Chahine L.M.; Ibanez L.; Screven L.; Ruffrage L.; Shulman L.; Marsili L.; Kuhl M.; Dean M.; Koretsky M.; Puckelwartz M.J.; Inca-Martinez M.; Louie N.; Mencacci N.E.; Albin R.; Alcalay R.; Walker R.; Chowdhury S.; Dumanis S.; Lubbe S.; Xie T.; Foroud T.; Beach T.; Sherer T.; Song Y.; Nguyen D.; Nguyen T.; Atadzhanov M.; Blauwendraat C.; Nalls M.A.; Foo J.N.; Mata I.; Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat Genet  2024,56(1),27-36","journal-title":"Nat Genet"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40779-023-00447-x","volume":"10","author":"Li Z.H.","year":"2023","unstructured":"Li Z.H.; Wang J.; Xu J.P.; Wang J.; Yang X.; Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research. Mil Med Res  2023,10(1),12","journal-title":"Mil Med Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/bs.pmbts.2024.07.005","volume":"208","author":"Poddar A.","year":"2024","unstructured":"Poddar A.; Ahmady F.; Prithviraj P.; Luwor R.B.; Shukla R.; Polash S.A.; Li H.; Ramakrishna S.; Kannourakis G.; Jayachandran A.; Advances in CRISPR\/Cas systems-based cell and gene therapy. Prog Mol Biol Transl Sci  2024,208(Jun),161-183","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/iep.12478","volume":"104","author":"Papaioannou I.","year":"2023","unstructured":"Papaioannou I.; Owen J.S.; Y\u00e1\u00f1ez-Mu\u00f1oz R.J.; Clinical applications of gene therapy for rare diseases: A review. Int J Exp Pathol  2023,104(4),154-176","journal-title":"Int J Exp Pathol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.ymthe.2018.10.017","volume":"26","author":"Salzman R.","year":"2018","unstructured":"Salzman R.; Cook F.; Hunt T.; Malech H.L.; Reilly P.; Foss-Campbell B.; Barrett D.; Addressing the value of gene therapy and enhancing patient access to transformative treatments. Mol Ther  2018,26(12),2717-2726","journal-title":"Mol Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-021-01487-4","volume":"21","author":"Rasul M.F.","year":"2022","unstructured":"Rasul M.F.; Hussen B.M.; Salihi A.; Ismael B.S.; Jalal P.J.; Zanichelli A.; Jamali E.; Baniahmad A.; Ghafouri-Fard S.; Basiri A.; Taheri M.; Strategies to overcome the main challenges of the use of CRISPR\/Cas9 as a replacement for cancer therapy. Mol Cancer  2022,21(1),64","journal-title":"Mol Cancer"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/genes14071469","volume":"14","author":"Umair M.","year":"2023","unstructured":"Umair M.; Waqas A.; Undiagnosed rare genetic disorders: Importance of functional characterization of variants. Genes (Basel)  2023,14(7),1469","journal-title":"Genes (Basel)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","volume":"23","author":"Chehelgerdi M.","year":"2024","unstructured":"Chehelgerdi M.; Chehelgerdi M.; Khorramian-Ghahfarokhi M.; Shafieizadeh M.; Mahmoudi E.; Eskandari F.; Rashidi M.; Arshi A.; Mokhtari-Farsani A.; Comprehensive review of CRISPR-based gene editing: Mechanisms, challenges, and applications in cancer therapy. Mol Cancer  2024,23(1),9","journal-title":"Mol Cancer"}],"container-title":["Current Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892029361490250310041259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240282\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892029361490250310041259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:42:37Z","timestamp":1788460957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240282\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892029361490250310041259","relation":{},"ISSN":["1389-2029"],"issn-type":[{"value":"1389-2029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}